{"gao_id": "GAO-09-819T", "published": "2009-06-24T13:00:00Z", "released": "2009-06-24T09:00:00Z", "summary": "", "title": "Prescription Drugs: Overview of Approaches to Control Prescription Drug Spending in Federal Programs", "topics": ["Generic drugs", "Prices and pricing", "Financial analysis", "Program abuses", "Medicare", "Cost awareness", "Prescription drugs", "Competition", "Health care programs", "Health care services", "Cost control", "Medicaid", "Health Care", "Program evaluation", "Beneficiaries", "Fees", "Pharmaceutical industry", "Congressional oversight", "Price regulation", "Program costs"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-09-819t", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-09-819t-highlights.pdf"}, {"title": "Full Report (16 pages)", "url": "https://www.gao.gov/assets/gao-09-819t.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a122834.html"}]}